<optgroup id="26a2n"></optgroup>

  • <ol id="26a2n"><output id="26a2n"></output></ol>

    <span id="26a2n"><sup id="26a2n"><object id="26a2n"></object></sup></span>
    <acronym id="26a2n"></acronym>
  • <legend id="26a2n"><i id="26a2n"></i></legend>

      1. <optgroup id="26a2n"><em id="26a2n"><pre id="26a2n"></pre></em></optgroup>


        1999


        In Shanghai, we established as a consultant firm in the chemical fields, and provided service Of synthesis route designing, patent information providing, technology transferring, and new Product launching support for the pharmaceutical company. During that time, we were acquainted with many important figures among the worldwide pharmaceutical giants, such as Pfizer, and Lilly.

        2003


        In Nanjing, we established our lab under the   help of Professor Mr. Li Jiaoyu from ChinaPharmaceutical University. We accumulated many useful resources in the consultant firm, so we provide the customer synthesis for the international famous pharmaceutical companies(Laboratory   scale). Once this phase is successful, we will enter pilot scale phase. And there areother three factories can provide us Outsourcing service.

        2008


        Chemieliva Pharmaceutical Co., Ltd was established, and the assets from the Consultant firm and laboratory had been injected in this new company. We   formed the business scope from LaboratoryR&D, pilot scale manufacturing,   industrialization manufacturing to contract manufacturing serviceand   international trading

        2010


        We signed the strategic contract with kimegle Industria e Comercio Ltda to engaged in the filedof emulsifier, which become another important business branch. 

        2013


        We bought 37% stock right of acinopeptide Co., Ltd, which professionally engaged in the production of Amino and Peptide and their derivatives only.

         

          重慶福騰醫藥化工有限公司
        爆乳喷汗肉感宝田萌奈美_99视频在线观看这里只有精品_亚洲综合日韩在线2019_亚洲欧美中文字幕无线码